Norges Bank Kymera Therapeutics, Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$29.85 - $39.42 $3.52 Million - $4.65 Million	117,883 New	117,883 $3.52 Million
Q4 2023 Feb 09, 2024	BUY	$10.97 - $26.84 $5.53 Million - $13.5 Million	504,083 New	504,083 $12.8 Million
Q3 2023 Nov 13, 2024	BUY	$13.9 - $23.88 $1.64 Million - $2.82 Million	117,883 New	117,883 $1.64 Million
Q3 2023 Nov 13, 2023	SELL	$13.9 - $23.88 $3.09 Million - $5.3 Million	-222,017 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$22.4 - $34.92 $1.11 Million - $1.73 Million	49,653 Added 42.12%	167,536 $3.85 Million
Q2 2023 Aug 14, 2023	SELL	$22.4 - $34.92 $5.34 Million - $8.33 Million	-238,417 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$24.84 - $38.75 $4.16 Million - $6.49 Million	167,536 New	167,536 $4.96 Million
Q4 2022 Feb 14, 2023	BUY	$19.57 - $30.92 $4.34 Million - $6.86 Million	222,017 New	222,017 $5.54 Million
Q3 2022 Nov 13, 2023	BUY	$20.91 - $34.27 $4.64 Million - $7.61 Million	222,017 New	222,017 $4.83 Million
Q2 2022 Aug 14, 2023	BUY	$14.13 - $42.55 $3.37 Million - $10.1 Million	238,417 New	238,417 $4.69 Million
Q1 2022 May 12, 2023	SELL	$35.3 - $64.68 $2.94 Million - $5.39 Million	-83,326 Reduced 37.53%	138,691 $5.87 Million
Q1 2022 May 09, 2022	SELL	$35.3 - $64.68 $1.91 Million - $3.5 Million	-54,163 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$49.91 - $65.56 $2.7 Million - $3.55 Million	54,163 New	54,163 $3.44 Million
Q3 2021 Nov 14, 2022	BUY	$47.8 - $66.66 $2.59 Million - $3.61 Million	54,163 New	54,163 $3.18 Million
Q3 2021 Nov 05, 2021	SELL	$47.8 - $66.66 $1.83 Million - $2.56 Million	-38,382 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$31.08 - $51.95 $1.19 Million - $1.99 Million	38,382 New	38,382 $1.86 Million
Q2 2021 Aug 10, 2021	SELL	$31.08 - $51.95 $684,692 - $1.14 Million	-22,030 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$35.64 - $85.46 $785,149 - $1.88 Million	22,030 New	22,030 $856,000
Q1 2021 May 07, 2021	SELL	$35.64 - $85.46 $534,600 - $1.28 Million	-15,000 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$28.07 - $87.83 $421,050 - $1.32 Million	15,000 New	15,000 $930,000
Q4 2020 Feb 10, 2021	SELL	$28.07 - $87.83 $421,050 - $1.32 Million	-15,000 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$26.1 - $33.28 $391,500 - $499,200	15,000 New	15,000 $485,000

Others Institutions Holding KYMR

# of Institutions

184

Shares Held

64.4M

Call Options Held

50.6K

Put Options Held

81.7K

Price T Rowe Associates Inc Baltimore, MD

6.65M
Shares

$270 Million
0.04% of portfolio
Baker Bros. Advisors LP New York, NY

6M
Shares

$243 Million
3.04% of portfolio
Bvf Inc San Francisco, CA

5.16M
Shares

$210 Million
7.77% of portfolio
Atlas Venture Life Science Advisors, LLC

4.9M
Shares

$199 Million
28.59% of portfolio
Vanguard Group Inc Valley Forge, PA

4.75M
Shares

$193 Million
0.0% of portfolio

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.22B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account